This topic contains a solution. Click here to go to the answer

Author Question: A type of inherited anemia that is a result of malfunctioning bone marrow is called: a. ... (Read 63 times)

mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
A type of inherited anemia that is a result of malfunctioning bone marrow is called:
 a. thalassemia.
  b. aplastic anemia.
  c. hemochromatosis.
  d. sickle cell anemia.

Question 2

If folate is administered orally to a patient who presents with anemia that is actually a B12-deficient anemia, the result is which of the following?
 a. the patient will expel the excess folate in the urine
  b. decrease in B12 levels
  c. irreversible neuropathy
  d. fatigue



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

b

Answer to Question 2

c



mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
Both answers were spot on, thank you once again



coreycathey

  • Sr. Member
  • ****
  • Posts: 333

 

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library